Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

NCT02343042

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Jonnsson Comprehensive Cancer Center / University of Los Angeles Los Angeles, California, United States
  • Sarah Cannon-Colorado Blood Cancer Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

NCT07479797

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta Newnan, Georgia, United States
View Trial Details
Recruiting

Actinium Therapy for Late-stage Aggressive Sarcomas

NCT07156565

Conditions
Advanced Soft Tissue Sarcoma, Disease Attributes, Neoplasms, +6 more
Locations
  • UCLA Los Angeles, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Memorial Sloane Kettering Cancer Center New York, United States
  • Case Western Cleveland, Ohio, United States
View Trial Details
Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions
Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • University of Florida Gainesville, Florida, United States
View all 20 locations
View Trial Details
Recruiting

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

NCT05184816

Conditions
Central Nervous System Neoplasms, Disease Attributes, Leptomeningeal Metastases, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

NCT05533697

Conditions
Advanced Solid Tumors, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
View all 39 locations
View Trial Details
Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT05519085

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Local Institution - 0366 Los Alamitos, California, United States
  • Local Institution - 0272 San Diego, California, United States
  • Local Institution - 0273 West Hollywood, California, United States
  • Local Institution - 0381 Aurora, Colorado, United States
View all 266 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View Trial Details

Related conditions